PATENT CLAIM ANALYSIS

Application Number: 15911816
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "272100"]

Abstract:
Immunogenic compositions and vaccines against Plasmodial infection comprising an Rh polypeptide or a fragment or variant thereof are disclosed. Also disclosed are Rh5 polypeptides or fragments or variants thereof capable of binding CD147 and conferring protection against infection and/or disease caused by multiple Plasmodial strains or Plasmodial species, inhibitors of the interaction between Rh5 and CD147 and methods for producing polypeptides in a mammalian expression system.

Claim (Index 9):
Use of the inhibitor of the interaction of Rh5 and CD147 in the preparation of a medicament for prevention and or treatment of  Plasmodium  infection and/or malarial disease.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 90.0
- Lexical Diversity: 1.40816
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14786509', '15507173', '11622845', '09500376', '15129230']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7256144485398764
- 35 USC 102 Novelty (BERT): 0.5322079868004229
- Combined Prediction Score: 0.7062738023659311
- Mean Citation Score: 299.076008
- Max Citation Score: 307.97726
- Similarity Product: 172.63045895463588

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test